SKI Market

A+| A| A-|

Indian Indices

Sensex

77,550.25 918.60
( 1.20%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aptus Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

544529

INE15XJ01010

29.1342566

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

248.4

EPS(TTM)

Face Value()

Div & Yield %

Back

PVV Infra consolidated net profit rises 10450.00% in the September 2025 quarter

Oct 04,2025

Net profit of PVV Infra rose 10450.00% to Rs 2.11 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 209.63% to Rs 10.93 crore in the quarter ended September 2025 as against Rs 3.53 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	10.93	3.53	210
OPM %	22.78	0.57	-
PBDT	2.49	0.02	12350
PBT	2.49	0.02	12350
NP	2.11	0.02	10450

77,550.25 918.60 ( 1.20%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,916.27 1,020.95 (1.83%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)